3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
4
Phase 3
4
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Keratosis, Actinic
5
Uterine Cervical Neoplasms
3
Uterine Cervical Dysplasia
2
Papillomavirus Infections
2
Melanoma
2
Hemangioma, Capillary
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1
Virus Diseases
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Skin Neoplasms
1
Sexually Transmitted Diseases
1
Precancerous Conditions
1
Pigmentation Disorders
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hemangioma
1
HPV
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Condylomata Acuminata
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Basal Cell
1
Carcinoma in Situ
1
Interventions
HhAntag691
15
sonidegib
5
cemiplimab
5
Nivolumab
5
Aminolevulinic Acid
5
daromun
4
Specimen Handling
4
Radiotherapy
3
Magnetic Resonance Spectroscopy
3
3-ingenyl angelate
3
tazarotene
2
relatlimab
2
Ipilimumab
2
IPI-926
2
Drug Evaluation
2
Celecoxib
2
Biopsy
2
talimogene laherparepvec
1
remetinostat
1
gusacitinib
1
endonuclease V, phage T4
1
X-Rays
1
Triamcinolone
1
Sutures
1
Surgical Procedures, Operative
1
Solutions
1
Papillomavirus Vaccines
1
Opdualag
1
Observation
1
Niacinamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Carcinoma, Basal Cell
×
Imiquimod
×
Clear all
NCT03534947
2025-12-16
SONIB
Melanoma Institute Australia
Phase 2
Completed
16 enrolled